Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Evaluation of New Drugs for Asthma and COPD: Endpoints, Biomarkers and Clinical Trial Designs — Peter J Barnes (2004) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Evaluation of New Drugs for Asthma and COPD: Endpoints, Biomarkers and Clinical Trial Designs
Shared by
Peter J Barnes
Imperial College London
Evaluation of New Drugs for Asthma and COPD: Endpoints, Biomarkers and Clinical Trial Designs
Chapter In A Book
2004
en
Authors
+3 more
Peter J Barnes
Imperial College London
EE
Edward M. Erin
TH
Trevor T. Hansel
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Chapter in a book
2009
Clinical Trials in Asthma and COPD: Trial Designs, Clinical Endpoints, and Biomarkers
Trevor T. Hansel
,
Andrew J. Tan
,
Peter J Barnes
Article
2006
ILV1 New drugs for asthma and COPD
Peter J Barnes
Book
2001
New Drugs for Asthma, Allergy and COPD
Trevor T. Hansel
,
Peter J Barnes
Chapter in a book
2010
New drugs and targets for asthma and COPD
Trevor T. Hansel
,
Peter J Barnes
Chapter in a book
2021
Other Drugs for Asthma and COPD
Peter J Barnes
Discussion(0)
No comments yet. Be the first to comment.